Attached files
| file | filename |
|---|---|
| EX-14.1 - EXHIBIT 14.1 CODE OF BUSINESS CONDUCT AND ETHICS - AXIM BIOTECHNOLOGIES, INC. | f10q093017_ex14z1.htm |
| EX-99.3 - EXHIBIT 99.3 AUDIT COMMITTEE CHARTER - AXIM BIOTECHNOLOGIES, INC. | f10q093017_ex99z3.htm |
| EX-99.2 - EXHIBIT 99.2 COMPENSATION COMMITTEE CHARTER - AXIM BIOTECHNOLOGIES, INC. | f10q093017_ex99z2.htm |
| EX-99.1 - EXHIBIT 99.1 NOMINATION COMMITTEE CHARTER - AXIM BIOTECHNOLOGIES, INC. | f10q093017_ex99z1.htm |
| EX-32.2 - EXHIBIT 32.2 SECTION 906 CERTIFICATION - AXIM BIOTECHNOLOGIES, INC. | f10q093017_ex32z2.htm |
| EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - AXIM BIOTECHNOLOGIES, INC. | f10q093017_ex31z2.htm |
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - AXIM BIOTECHNOLOGIES, INC. | f10q093017_ex31z1.htm |
| 10-Q - FORM 10-Q QUARTERLY REPORT - AXIM BIOTECHNOLOGIES, INC. | f10q093017_10q.htm |
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Axim Biotechnologies, Inc., a Nevada corporation, (the “Registrant”) on Form 10-Q for the interim period ended September 30, 2017 (the “Report”), I, Dr. George Anastassov, Chief Executive Officer of the Registrant, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Dated: November 17, 2017 | By: | /s/ Dr. George Anastassov |
|
| Dr. George Anastassov Chief Executive Officer (Principal Executive Officer) |